Discussion about this post

User's avatar
David AuBuchon's avatar

Speaking of reanalysis...

https://openvaet.substack.com/p/pfizerbiontech-c4591001-trial-audit

https://wherearethenumbers.substack.com/p/anomalous-patterns-of-mortality-and

Pfizer's vaccine trial data is so garbled and fraudulent that reanalysis literally can't even be done. Tell Vinay to read these and show them to Dr. Makary as the new FDA comissioner. This product needs to be pulled from the market. Pfizer needs to be sued into oblivion. Doctors need to be in some way reprimanded.

Edit: To clarify, just a few of things that have been found:

- imbalanced comorbidities (i,e, not a randomized trial)

- massive unblinding on several accounts (i.e. not a double-blind trial)

- two different products were tested, the latter of which only in a couple hundred people, with a worse side effect profile, and that's what hte public got (i.e. literally didn't test what they said they tested)

- tested the unvaccinated for covid way more (should not happen if blinded)

- disappeared hundreds of patients

- reclassified side effects as covid cases

- supressed serious injuries

- unnatural time distribution of deaths (i.e. not possible without doing funny business)

- and so much more...

Litmus test in progress for the guys at Sensible Medicine... If they can't wake up, then who the hell can.?

Expand full comment
Florence LeCraw's avatar

Even if medical journals require that all authors make their de-identified data and codes available, there is no incentive for most researchers to reanalyze a study unless they don't care about advancing their career. Publications help advance careers. Unlike economic journals, medical journals rarely if ever publish replication papers. Incentives matter.

I believe that we have a better chance to get replication papers published in medical journals now than ever. Jay Bhattacharya is an advocate for the Open Science movement. He has been nominated to be the Director of NIH. (My fingers are crossed.) Senator Bill Cassidy, a gastroenterologist and author of the white paper "NIH In the 21st Century: Ensuring Transparency and American Biomedical Leadership" will be Chairman of the Senate's HELP Committee. The NIH is in the process of revising their policies as required by a bill passed in Congress in the 80's. John Ioannidis, Brian Nosek, Tom Mroz, and I met with Kathryn Bell, who co-authored Cassidy's white paper, about many of the issues that Sensible Medicine has raised.. My ask to Kathryn was for Cassidy to help the NIH to incentivize medical journals to publish replication papers. I believe that this may be the right time, the right place, and the right people to accomplish Sensible Medicine and its readers' goals. If you can help Senator Cassidy, Jay, and the many others who are working to advancie the Open Science movement, please do so. You are sorely needed.

Expand full comment
20 more comments...

No posts